Odyssey Therapeutics
Latest round
- Series D
Last raised
- Jun 2025
Total raised
- $571M
Investors
- 28
About Odyssey Therapeutics
Based in Massachusetts, US, and founded in 2021 by Eicke Latz, Kim Lewis, Felix Meissner, and Florian Schmidt, Odyssey Therapeutics Inc. develops anti-inflammation immunotherapies to treat inflammatory diseases and cancer. As of February 2024, Gary D. Glick is the CEO of the company. Odyssey Therapeutics Inc. develops novel therapeutics for patients with autoimmune diseases using modern machine-learning techniques. Its offerings include immunomodulators, oncology medicines, and many others.
Who invested in Odyssey Therapeutics
28 investors across 4 rounds
See all investors in Odyssey Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Odyssey Therapeutics
Who invested in Odyssey Therapeutics?
Odyssey Therapeutics has 28 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Odyssey Therapeutics raised?
Odyssey Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Odyssey Therapeutics last raise money?
Odyssey Therapeutics's most recent round on record is a Series D, in Jun 2025.
What does Odyssey Therapeutics do?
Based in Massachusetts, US, and founded in 2021 by Eicke Latz, Kim Lewis, Felix Meissner, and Florian Schmidt, Odyssey Therapeutics Inc.
Where is Odyssey Therapeutics headquartered?
Odyssey Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Odyssey Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Odyssey Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Odyssey Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.